Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 1. Main autopsy findings in a kidney transplant recipient with fatal YF. A, Liver with brown-yellowish cut ... Figure 1. Main autopsy findings in.

Published byLadislav Valenta Modified over 5 years ago

Similar presentations

Presentation on theme: "Figure 1. Main autopsy findings in a kidney transplant recipient with fatal YF. A, Liver with brown-yellowish cut ... Figure 1. Main autopsy findings in."— Presentation transcript:

1 Figure 1. Main autopsy findings in a kidney transplant recipient with fatal YF. A, Liver with brown-yellowish cut ... Figure 1. Main autopsy findings in a kidney transplant recipient with fatal YF. A, Liver with brown-yellowish cut surface due to steatosis; B, Histological aspect of a severe YF hepatitis affecting the entire hepatic lobe, reaching the periportal area, with steatotic (thick arrows) and apoptotic (thin arrows) hepatocytes, Kupffer cell hyperplasia, and minimal inflammatory reaction; C, Immunohistochemistry reaction detecting YF virus antigens in the cytoplasm of steatotic and apoptotic hepatocytes (arrow). D, Pancreas with diffuse ischemic/reperfusion pancreatitis, with numerous hemorrhagic steatonecrosis spots (arrow). E, Coronal cut of brain showing diffuse perivascular microhemorrhages (arrow) in the white matter. Scale bars: 50 µm in B and C. Abbreviation: YF, yellow fever. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Clinical Infectious Diseases, ciz389, The content of this slide may be subject to copyright: please see the slide notes for details.

Download ppt "Figure 1. Main autopsy findings in a kidney transplant recipient with fatal YF. A, Liver with brown-yellowish cut ... Figure 1. Main autopsy findings in."

Similar presentations

Figure 1. Overview of protein microarray titers for all hemagglutinin (HA) part antigens, by diet and species. Antigens ... Figure 1. Overview of protein.

Figure 1. Overview of protein microarray titers for all hemagglutinin (HA) part antigens, by diet and species. Antigens ... Figure 1. Overview of protein.
(A) Axial view of gadolinium-enhanced ...

(A) Axial view of gadolinium-enhanced ...
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1 Flowchart of our CIS cohort considering patients (A) and eyes (B) as statistical unit. Unless provided in the caption above, the following copyright.

Figure 1 Flowchart of our CIS cohort considering patients (A) and eyes (B) as statistical unit. Unless provided in the caption above, the following copyright.
Figure 1 Data-selection process

Figure 1 Data-selection process
Figure 1 Flow diagram detailing the systematic review process.

Figure 1 Flow diagram detailing the systematic review process.
Figure 3. Acid-fast stain of the specimen showed acid-fast bacilli distributed in a perineural and periadnexal manner ... Figure 3. Acid-fast stain of.

Figure 3. Acid-fast stain of the specimen showed acid-fast bacilli distributed in a perineural and periadnexal manner ... Figure 3. Acid-fast stain of.
Figure 1 Schematic representation of the experimental design.

Figure 1 Schematic representation of the experimental design.
Figure 1 Mechanism of mortality benefit associated with radial access

Figure 1 Mechanism of mortality benefit associated with radial access
Figure 1. Mean earnings of men and women over the early career (with 95 per cent confidence intervals) Figure 1. Mean earnings of men and women over the.

Figure 1. Mean earnings of men and women over the early career (with 95 per cent confidence intervals) Figure 1. Mean earnings of men and women over the.
Fig. 1. Relative potency ratios of 13 active ingredients used against a fall armyworm population collected in Puerto ... Fig. 1. Relative potency ratios.

Fig. 1. Relative potency ratios of 13 active ingredients used against a fall armyworm population collected in Puerto ... Fig. 1. Relative potency ratios.
Figure 1 Phases of the research. Author’s own work.

Figure 1 Phases of the research. Author’s own work.
(A–B) Images of US ... (A–B) Images of US assessment of both patients who developed peripheral arthritis during vedolizumab treatment undergoing US-guided.

(A–B) Images of US ... (A–B) Images of US assessment of both patients who developed peripheral arthritis during vedolizumab treatment undergoing US-guided.
Figure 1. Multivariable-adjusted hazard ratios (solid line) for incident chronic obstructive pulmonary disease as a ... Figure 1. Multivariable-adjusted.

Figure 1. Multivariable-adjusted hazard ratios (solid line) for incident chronic obstructive pulmonary disease as a ... Figure 1. Multivariable-adjusted.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1 Mean (±SE) egg investment in female zebra finches shortly after a second injection with either tetanus toxoid ... Figure 1 Mean (±SE) egg investment.

Figure 1 Mean (±SE) egg investment in female zebra finches shortly after a second injection with either tetanus toxoid ... Figure 1 Mean (±SE) egg investment.
Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.

Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.
AHA: American Heart Association; ALT: ...

AHA: American Heart Association; ALT: ...
Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.

Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.
Figure 1 A dot plot illustrating the correlation between the yearly absolute risk difference for both MACE and major ... Figure 1 A dot plot illustrating.

Figure 1 A dot plot illustrating the correlation between the yearly absolute risk difference for both MACE and major ... Figure 1 A dot plot illustrating.

Similar presentations

Ads by Google